Hence, high RvD scores are associated with improved outcomes and enhanced CD8+ T cell anti-tumor immunity, suggesting that stimulation of the RvD pathway may prime leukocyte-dependent inhibition of HNSC cancer progression. The gene discussed is CD8A; the disease is cancer.